Moderna (MRNA) Prepaid Assets (2017 - 2026)
Moderna (MRNA) posted quarterly Prepaid Assets of $380.0 million for Q2 2026, down 50.26% year-over-year from $764.0 million in Q2 2025, and up 9.2% on a QoQ basis from $348.0 million in Q1 2026.
Moderna (MRNA) Prepaid Assets (2017 - 2026) Analysis & Trends
Moderna has reported Prepaid Assets for 10 years, with the latest figure at $380.0 million in Q2 2026.
- Prepaid Assets for Q2 2026 came in at $380.0 million, down 50.26% year-over-year; the trailing twelve-month figure through Jun 2026 was $380.0 million (down 50.26% YoY), and the FY2025 annual result was $408.0 million, down 31.89% from the prior year.
- Prepaid Assets advanced to $380.0 million in Q2 2026, from $348.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.4 billion in Q1 2023 and troughed at $348.0 million in Q1 2026.
- A 5-year average of $804.0 million and a median of $740.0 million in 2025 frame the typical range for Prepaid Assets.
- The widest annual swing landed in 2022, when Prepaid Assets soared 324.24%; it then slumped 52.36% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $1.2 billion in 2022, then plunged by 47.53% to $627.0 million in 2023, then slipped by 4.47% to $599.0 million in 2024, then plunged by 31.89% to $408.0 million in 2025, then fell by 6.86% to $380.0 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $380.0 million in Q2 2026, $348.0 million in Q1 2026, and $408.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 380.00 Mn |
| Mar 31, 2026 | 51.00 Mn |
| Dec 31, 2025 | 45.00 Mn |
| Sep 30, 2025 | 56.00 Mn |
| Jun 30, 2025 | 57.00 Mn |
| Mar 31, 2025 | 585.00 Mn |
| Dec 31, 2024 | 599.00 Mn |
| Sep 30, 2024 | 46.00 Mn |
| Jun 30, 2024 | 31.00 Mn |
| Mar 31, 2024 | 68.00 Mn |
| Dec 31, 2023 | 88.00 Mn |
| Sep 30, 2023 | 873.00 Mn |
| Jun 30, 2023 | 1.19 Bn |
| Mar 31, 2023 | 1.35 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.18 Bn |
| Jun 30, 2022 | 76.00 Mn |
| Mar 31, 2022 | 36.00 Mn |
| Dec 31, 2021 | 728.00 Mn |
| Sep 30, 2021 | 412.00 Mn |